10 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 13 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 13 | Completed 10, Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
Follow Fytexia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GreenArt: Nutrikinetics and Bioavailability Studies GreenArt D is a baccharis-type propolis powder extract containing phenolic compounds such as prenylated phenylpropanoids derived from hydroxycinnamic acids and flavonoids., GreenArt 4D is a baccharis-type propolis powder extract containing phenolic compounds such as prenylated phenylpropanoids derived from hydroxycinnamic acids and flavonoids., Placebo - Nutrition, Healthy | Not applicable | Not yet recruiting | Fytexia | 10 | 2026-06-01 | 2026-07-02 |
| Modulation of Appetite Signaling Through Enterohormone Stimulation by DNF-10 DNF-10: 500 mg/day, Placebo: 500 mg maltodextrin/day - Healthy Adult | Not applicable | Recruiting | Fytexia | 50 | 2026-05-12 | 2026-10-23 |
| Oral Bioavailability of the Phenolic Compounds in a Melissa Supplement Placebo, M_ML - Nutrition, Healthy | Not applicable | Completed | Fytexia | 10 | 2025-04-30 | 2025-06-15 |
| Poplar-type Propolis Dry Extract ESIT12 : Nutrikinetic and Bioavailability Studies ESIT12 D, ESIT12 4D, Placebo - Nutrition, Healthy | Not applicable | Completed | Fytexia | 10 | 2023-07-22 | 2023-12-08 |
| OXXYNEA® GS: Study for Glycaemia Management Verum A, Verum B, Placebo - Prediabetic State, Overweight | Not applicable | Active not recruiting | Fytexia | 87 | 2023-07-05 | 2025-09-18 |
| Poplar-type Propolis Dry Extract ESIT12 : Immunomodulation Efficacy Study Placebo, Verum - Upper Respiratory Tract Infection (URTI) | Not applicable | Completed | Fytexia | 309 | 2022-12-05 | 2024-09-25 |
| Evaluation of OxxyneaGS in Acute Glycemic Regulation on Light Hyperglycemic Subjects Verum T1, Verum T2, Verum T3 - Hyperglycemia, Postprandial | Not applicable | Completed | Fytexia | 10 | 2021-06-15 | 2022-08-10 |
| Evaluation of Mangoselect® in Improvement of Exercise/Activity-induced Knee Joint Discomfort in Subjects Suffering From Osteoarthritis Grade I or II Placebo, Verum A, Verum B - Osteoarthritis, Knee | Not applicable | Completed | Fytexia | 95 | 2021-03-01 | 2023-12-05 |
| Mangoselect®: Characterization, Pharmacokinetics and Bioavailability of Xanthone Metabolites MNGDPF, MNGEF - Dietary Modification | Not applicable | Completed | Fytexia | 10 | 2019-11-11 | 2020-02-07 |
| Bioavailability, Pharmacokinetic and Mechanistic Study of Sinetrol® Xpur, a Polyphenol-rich Ingredient Verum900, Verum1800 - Overweight | Not applicable | Completed | Fytexia | 20 | 2019-03-08 | 2019-11-01 |
| Evaluation of Bioavailability of Phenolic Compounds From Oxxynea® Oxxynea®, Placebo - Dietary Modification | Not applicable | Completed | Fytexia | 10 | 2018-02-23 | 2018-03-13 |
| Evaluation of Sinetrol® Xpur in Fat Mass Reduction on Overweight and Obese Subjects Placebo, Sinetrol® Xpur - Change in Total Body Fat Mass Percentage Loss Versus Body Weight | Not applicable | Completed | Fytexia | 77 | 2015-04-01 | 2019-11-04 |
| Evaluation of Fiit-ns® in Health-related Quality of Life Improvement in Overweight and Obese Subjects Fiit-ns®, Placebo - Overweight and Obesity | Not applicable | Completed | Fytexia | 92 | 2015-04-01 | 2018-02-06 |
Overweight (3) · Hyperglycemia (1) · Obesity (1) · Osteoarthritis, Knee (1) · Prediabetic State (1) · Respiratory Tract Infections (1)
Flavonoids (1) · Oxxynea (1) · calcium D-pantothenate, L-cysteine drug combination (1)
Spain (13)
Pedro Alcaraz (4) · Pedro E Alcaraz Ramon (3) · Pedro Alcaraz Ramon (2) · Antoni Caimari Palou, PhD (1) · Pedro E. Alcaraz, PhD (1)